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Introduction
Juvenile idiopathic arthritis (JIA) is a heterogeneous group
of disorders grouped in 7 categories. The prognosis of JIA
patients varies markedly, even within these categories and
ranges from mild inflammation of a single joint to involve-
ment of multiple joints leading to damage and incapacity.
The goal of treatment is to avoid these long-term sequelae
and on the other hand to spare children with milder
disease aggressive therapy. To achieve this and to inform
patients and their parents correctly about the disease, it is
essential to know the prognosis in the individual patient,
preferably already at the time of diagnosis.
Objectives
The aim of this study was to identify factors, which predict
disease activity, joint damage, functional ability and quality
of life (QoL) early in the course of disease.
Methods
A systematic literature review was performed in PubMed,
Embase, The Cochrane Library and PsycInfo and 3,679
articles were identified. The results were screened and
critically appraised, using predefined criteria. Articles
about studies that used validated outcomes, such as the
Wallace criteria for disease remission, the childhood
health-assessment questionnaire (CHAQ) and the juvenile
arthritis damage index (JADI) and which determined
predictors in the first 6 months of disease were selected.
Results
Forty relevant articles were selected. Most of them were
retrospective studies and many did not perform a multi-
variate analysis. The studies mostly evaluated basic demo-
graphic, clinical and laboratory predictors. Polyarticular
onset predicted a worse prognosis for all outcomes, except
QoL. A diagnostic delay and the systemic category pre-
dicted continuation of active disease. Notably, antinuclear
antibodies (ANA) did not predict disease activity. Sym-
metric involvement and rheumatoid factor positivity pre-
dicted less damage. More disease activity was mainly
associated with worse functional outcome. However, most
predictors were not validated.
Conclusion
Few factors were predictive of JIA prognosis. Validation of
these predictors in independent cohorts was still lacking
in many cases. Overall, demographic, clinical and routine
laboratory values were insufficient as early predictors for
the outcome in JIA. Prospective, longitudinal studies,
using standardized outcome measurements, such as the
Wallace criteria and the CHAQ, and evaluating a broader
range of predictors, such as genetics, immunologic and
imaging data, should be performed. For the outcomes
joint assessment and quality of life, standardized and
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